Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 13, 2022
Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implicationsK W Miskowiak, L Fugledalen, A E Jespersen, et al.
European Journal of Haematology|September 21, 2000
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myelomaN Abildgaard, H Glerup, J Rungby, et al.
Translational Psychiatry|March 1, 2017
High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortexJ K Lauridsen, R H Olesen, J Vendelbo, et al.
American Journal of Therapeutics|April 29, 2006
Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugsS P Johnsen, T B M Monster, M L Olsen, et al.
BMJ Open|September 27, 2013
Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010V Ehrenstein, R K Hernandez, S P Ulrichsen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2012
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetesM Gejl, H M Søndergaard, C Stecher, et al.
Diabetologia|November 25, 2010
Comparison of two sulfonylureas with high and low myocardial K(ATP) channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetesS B Kristiansen, B Løfgren, J M Nielsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 3, 2015
Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetesA Mor, K Berencsi, E Svensson, et al.
Diabetes/Metabolism Research and Reviews|November 25, 2017
Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 studyA Bo, R W Thomsen, J S Nielsen, et al.
Diabetes Research and Clinical Practice|January 24, 2025
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendationsC Brock, H Andersen, A C Alibegovic, et al.
Pageof 19